[Clinical testing of a new local corticoid: desoximethasone].
In a double-blind comparative trial on 37 patients with symetric dermatoses, the clinical effect of desoximetasone (0.25%) has been compared to fluocinolone acetonide (0.2%). After 7 days of treatment an improvement or cure of the lesions could be seen in 34 patients treated with desoximetasone, and only on 22 patients treated with fluocinolone acetonide (0.2%). The better effect of desoximetasone was especially evident on erythema and pruritus. Differences between the drugs were statistically significant.
D003877:Dermatitis, Contact / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003907:Dexamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D008010:Lichen Planus / Q000188:drug therapy; D010915:Pityriasis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy
D005446:Fluocinolone Acetonide; D003907:Dexamethasone
Klinische Erprobung eines neuen lokalen Kortikoids: Desoximetason